Bluewater Bio
Muhannad Odeibat serves as the VP Sales MENA at Bluewater Bio since October 2024, bringing extensive experience in sales and business development across the Middle East region. Prior roles include Sales & Business Development Manager MENA at Osmoflo from September 2023 to September 2024, and Sales Manager Middle East at CERAFILTEC from February 2022 to September 2023. Muhannad's career includes a lengthy tenure at Xylem Water & Wastewater as Sales Manager from July 2012 to February 2022, as well as Regional Branch Manager at WETICO from February 2002 to June 2012. Education was completed at Jordan University of Science and Technology, where a Bachelor's degree in Mechanical Engineering was obtained from 1993 to 1998.
This person is not in any teams
This person is not in any offices
Bluewater Bio
The UK's fastest growing Water Company, Bluewater Bio is an award-winning specialist in the cost effective treatment of water and wastewater. Headquartered in London, Bluewater Bio’s range of best in class technologies have been deployed at over 100 sites globally. With two fully commercialised technologies proven at utility scale, complemented by an active New Product development pipeline Bluewater Bio’s capabilities now include: • HYBACS® (cost-effective activated sludge upgrade) • FilterClear™ (high throughput multi-media filtration) • CFIC® (next-generation moving bed bioreactor (MBBR) technology) • NeoTech (low energy, high reflectivity UV disinfection) • Operational & Maintenance services (supporting a population equivalent of c. 1 million) • World class R&D team, based at Cranfield University, UK Bluewater Bio’s growing technology portfolio is focused primarily on the rapid upgrading, optimisation and monitoring of water and wastewater treatment plants. The company has a particular emphasis on reducing: The company has a particular emphasis on reducing: • CAPEX & OPEX • Energy & chemical consumption • Physical & environmental footprint • GreenHouse Gas emissions – operational and embedded BwB not only develops its own innovations but also scours adjacent markets for complementary IP, licence opportunities and partnerships. Through this aggregation strategy, BwB aims to be the natural choice for cost effective treatment, re-use and monitoring provision across the water, wastewater and process industries.